
Advances in Pharmacology
Description
Alles über E-Books | Antworten auf Fragen rund um E-Books, Kopierschutz und Dateiformate finden Sie in unserem Info- & Hilfebereich.
More details
Other editions
Additional editions
Persons
Content
- Cover
- Contents
- Contributors
- Chapter 1. Hypotensive Peptides: Bradykinin, KalMin, and Eledoisin
- I. Introduction
- II. Releasing Enzymes (Kininogenases)
- III. Kininogen (Kallidinogen, Bradykininogen)
- IV. Kinins (Bradykinin, Kallidin, Met-Lys-Bradykinin)
- V. Eledoisin
- VI. Conclusions
- References
- Chapter 2. Uricosuric Drugs, with Special Reference to Probenecid and Sulfinpyrazone
- I. Uricosuric Activity Defined
- II. Physiological Basis for Use of Uricosuric Drugs
- III. Nature of Uricosuric Response in Normal and Gouty Man
- Species-Dependency
- IV. The Search for a Suitable Uricosuric Agent
- V. The Akylsulfonamidobenzoic and N-Alkylsulfamylbenzoic Acids
- VI. The Pyrazolidinediones
- VII. Incidental Compounds Possessing Uricosuric Properties: Phenolsulfonphthalein, Mersalyl, Iodopyracet, Corticotropin and Adrenocortical Steroids, Coumarins and Indandiones, Chlorprothixene, Acetohexamide, Ethyl-p-chlorophenoxyisobutyrate. The Paradoxical Action of Benzothiadiazines
- References
- Chapter 3. Synthetic Anti-Inflammatory Drugs: Concepts of Their Mode of Action
- I. Introduction
- II. Former Interpretations of the Effects of Antipyretic/Non-Narcotic Analgesic Drugs
- III. The Pituitary-Adrenal Axis and Drug-Induced Inhibition of Inflammation
- IV. The Inflammatory Focus as Site of Action of Anti-Inflammatory Drugs
- V. Summary
- References
- Chapter 4. Biochemistry of Drug Oxidation and Reduction by Enzymes in Hepatic Endoplasmic Reticulum
- I. Introduction
- II. Oxidation of Foreign Compounds by Enzymes in Hepatic Endoplasmic Reticulum
- III. Reduction of Foreign Compounds by Enzymes in Hepatic Endoplasmic Reticulum
- IV. Mechanisms of Oxidation and Reduction by Enzymes in Hepatic Endoplasmic Reticulum
- V. Factors Which Limit Drug Metabolism in Living Animals
- References
- Chapter 5. Experimental and Clinical Chemoteratogenesis
- I. Introduction
- II. General Survey
- III. General Principles
- IV. Experimental Conditions
- V. Experimental Techniques
- VI. Teratogenic Drugs
- VII. Nature and Mechanism of Action of Teratogenic Drugs
- VIII. Conclusions
- Glossary
- References
- Author Index
- Index
System requirements
File format: PDF
Copy protection: Watermark-DRM (Digital Rights Management)
System requirements:
- Computer (Windows; MacOS X; Linux): Use the free software Adobe Reader, Adobe Digital Editions, or any other PDF viewer of your choice (see eBook Help).
- Tablet/Smartphone (Android; iOS): Install the free app Adobe Digital Editions or another reading app for eBooks, e.g., PocketBook (see eBook Help).
- E-reader: Bookeen, Kobo, Pocketbook, Sony, Tolino and many more (only limited: Kindle).
The file format PDF always displays a book page identically on any hardware. This makes PDF suitable for complex layouts such as those used in textbooks and reference books (images, tables, columns, footnotes). Unfortunately, on the small screens of e-readers or smartphones, PDFs are rather annoying, requiring too much scrolling.
This eBook uses Watermark-DRM, a „soft” copy protection. This means that there are no technical restrictions to prevent illegal distribution. However, there is a personalised watermark embedded in the eBook that can be used to identify the purchaser of the eBook in the event of misuse and to provide evidence for legal purposes.
For more information, see our eBook Help page.